A patient-derived serous ovarian cancer cell line, reported as a post-treatment platinum-resistant counterpart to PEO14, and used to study drug resistance and disease heterogeneity. Exlcusive to CancerTools. Save 30% on this cell line this summer. Use code SUM26CELL at checkout.
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.